Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues.
Vermeer MC, Bolling MC, Bliley JM, Arevalo Gomez KF, Pavez-Giani MG, Kramer D, Romero-Herrera PH, Westenbrink BD, Diercks GF, van den Berg MP, Feinberg AW, Silljé HHW, van der Meer P. Vermeer MC, et al. Among authors: van den berg mp, van der meer p. J Clin Invest. 2021 Jul 22;131(17):e140615. doi: 10.1172/JCI140615. Online ahead of print. J Clin Invest. 2021. PMID: 34292882 Free PMC article.
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH. van der Meer P, et al. Among authors: van de wal rm, van gilst wh, van veldhuisen dj. Circulation. 2005 Sep 20;112(12):1743-7. doi: 10.1161/CIRCULATIONAHA.105.549121. Circulation. 2005. PMID: 16172283
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
Lipsic E, van der Meer P, Voors AA, Westenbrink BD, van den Heuvel AF, de Boer HC, van Zonneveld AJ, Schoemaker RG, van Gilst WH, Zijlstra F, van Veldhuisen DJ. Lipsic E, et al. Among authors: van gilst wh, van den heuvel af, van der meer p, van zonneveld aj, van veldhuisen dj. Cardiovasc Drugs Ther. 2006 Apr;20(2):135-41. doi: 10.1007/s10557-006-7680-5. Cardiovasc Drugs Ther. 2006. PMID: 16761193 Clinical Trial.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van der meer p, van veldhuisen dj. Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17. Eur Heart J. 2007. PMID: 17576662
Heart failure highlights in 2011.
Westenbrink BD, Damman K, Rienstra M, Maass AH, van der Meer P. Westenbrink BD, et al. Among authors: van der meer p. Eur J Heart Fail. 2012 Oct;14(10):1090-6. doi: 10.1093/eurjhf/hfs121. Epub 2012 Aug 16. Eur J Heart Fail. 2012. PMID: 22898804 Free article. Review.
Erythropoietin and heart failure: the end of a promise?
Kleijn L, Westenbrink BD, van der Meer P. Kleijn L, et al. Among authors: van der meer p. Eur J Heart Fail. 2013 May;15(5):479-81. doi: 10.1093/eurjhf/hft058. Epub 2013 Apr 4. Eur J Heart Fail. 2013. PMID: 23558218 Free article. No abstract available.
Sex differences in cardiomyopathies.
Meyer S, van der Meer P, van Tintelen JP, van den Berg MP. Meyer S, et al. Among authors: van den berg mp, van der meer p, van tintelen jp. Eur J Heart Fail. 2014 Mar;16(3):238-47. doi: 10.1002/ejhf.15. Epub 2014 Jan 16. Eur J Heart Fail. 2014. PMID: 24464619 Free article. Review.
611 results